Ireland
--:--IST
Latest
Clinical Trials in Canada / NCT07747831
Starting soon Not applicable

Powered Impaction and Broaching in Elderly Total Hip Arthroplasty

NCT07747831 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-10-01
Last updated
2026-08-05

Condition(s) studied

Hip Arthroplasty ReplacementGait BiomechanicsSurgeon Physiologic Stress

Investigational drug(s) / intervention(s)

Total Hip Replacement with Automatic impaction and broaching deviceTotal Hip Replacement

Total Hip Replacement with Automatic impaction and broaching device: Total hip replacement with the use of an automatic impaction and broaching device

Total Hip Replacement: Total hip replacement without automatic impaction and broaching

Study summary

Placing the parts of a hip replacement requires substantial force. This can lead to additional stress on the surgeon as well as the bone. A device was developed to help reduce this stress. This study aims to see whether this device impacts implant positioning and the surrounding bone in patients 70 years and older. It also will investigate surgeon efficiency and how patients walk after surgery.

Eligibility

Sex
ALL
Min age
70 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Patients 70 years or older undergoing total hip replacement Exclusion Criteria: * Unable to undergo the informed consent process

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Concordia Joint Replacement Group / Concordia Hospital Winnipeg Manitoba
Nova Scotia Health Halifax Nova Scotia

More Nova Scotia Health Authority trials in Canada

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07747831 on ClinicalTrials.gov ↗ ← All trials in Canada